A study conducted in Dubai demonstrated that carriers with null GSTM1 genotype had a high risk of developing COPD, especially with both null GSTT1 and GSTM1 haplotype 31. This evidence concerns the gene GSTM1 and chronic obstructive pulmonary disease.